Global supply chain management provider, Ligentia, has secured major investment from European private equity investors Equistone to support its continued international expansion.
The company, based at Nexus, manages the international freight and supply chains for some of the world’s leading retailers, consumer brands and healthcare providers. The £300 million revenue business aims to expand through global acquisitions, with an ambition to grow to £1 billion in the next five years.
Founder and Chief Executive Nick Jones comments: “Equistone has an exceptional track record of supporting fast-growth global companies like ours, as well as a deep understanding of the market. We’re really excited about this next part of our journey with a valuable partner on board.”
Dr Martin Stow, Nexus Director said: “This is an incredible achievement for Ligentia, just a year after they relocated their software development division from Asia to join the Nexus business community here in Leeds. One of our key aims has always been to create a community where innovative, technology-led businesses can scale and expand on the international stage and Ligentia is an inspiring example of that success.”
Equistone is a stakeholder in a wide range of businesses in the retail, healthcare, food, energy and industrial sectors. Director Sebastien Leusch comments:
“Ligentia has 25 years of experience in global supply chain management with some of the world’s most admired brands. Thanks to its strong management team, the business is known for its particularly high customer service levels, underpinned by a standout technology platform.”
Interested in finding out more about how being part of the Nexus community could benefit your business? Get in touch with us.
Investment Zone boosts Leeds’ innovation ambitions and vision
The investment in digital and healthtech will accelerate plans for the Leeds Innovation Arc, kickstarting the development of the Innovation Village on the Leeds General Infirmary site with the refurbishment of the Old Medical School to create a healthtech innovation hub.